Top Markets
#1 Black Phoenix Black Phoenix +734.40%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.03%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +18.07%
#4 MetaDAO MetaDAO +16.03%
#5 TENDIES TENDIES +15.97%
#6 THORChain THORChain +10.84%
#7 The Bitcoin Bull The Bitcoin Bull +10.30%
#8 Akedo Akedo +9.33%
#9 XYO Network XYO Network +8.50%
#10 PondCoin PondCoin +8.38%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

002317
Rank in Stocks #5051
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Share Price
$3.57
Market Cap
$3.04B
Change (1 day)
0.16%
Change (1 year)
19.91%
Country
CN
Trade Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)

Category

Healthcare
Revenue for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Revenue in Aug 2026 TTM: 0
According to Guangdong Zhongsheng Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Guangdong Zhongsheng Pharmaceutical Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN